Real-time Estimate
Tradegate
09:06:03 2024-05-28 am EDT
|
5-day change
|
1st Jan Change
|
37.02
EUR
|
+0.07%
|
|
+4.65%
|
-12.26%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,140
|
3,067
|
4,808
|
2,020
|
2,280
|
1,992
|
-
|
-
|
Enterprise Value (EV)
1 |
2,606
|
3,554
|
5,206
|
2,388
|
3,216
|
2,780
|
2,691
|
2,611
|
P/E ratio
|
27.8
x
|
35.8
x
|
23
x
|
15.1
x
|
36.5
x
|
21.1
x
|
15.4
x
|
14.3
x
|
Yield
|
2.01%
|
1.54%
|
2.43%
|
2.8%
|
2.08%
|
2.43%
|
3.25%
|
3.65%
|
Capitalization / Revenue
|
3.05
x
|
3.86
x
|
5.1
x
|
1.97
x
|
2.01
x
|
1.71
x
|
1.63
x
|
1.55
x
|
EV / Revenue
|
3.72
x
|
4.48
x
|
5.52
x
|
2.33
x
|
2.83
x
|
2.38
x
|
2.21
x
|
2.03
x
|
EV / EBITDA
|
14.7
x
|
17.7
x
|
14.8
x
|
6.64
x
|
10.4
x
|
9.31
x
|
8.25
x
|
7.6
x
|
EV / FCF
|
-9.25
x
|
39.4
x
|
27.5
x
|
9.57
x
|
18.1
x
|
15.4
x
|
16.1
x
|
14.5
x
|
FCF Yield
|
-10.8%
|
2.54%
|
3.63%
|
10.4%
|
5.53%
|
6.51%
|
6.2%
|
6.88%
|
Price to Book
|
7.68
x
|
9.52
x
|
9.67
x
|
3.8
x
|
4.23
x
|
3.4
x
|
2.89
x
|
2.68
x
|
Nbr of stocks (in thousands)
|
53,840
|
53,840
|
53,840
|
53,840
|
53,840
|
53,840
|
-
|
-
|
Reference price
2 |
39.75
|
56.96
|
89.30
|
37.52
|
42.34
|
37.00
|
37.00
|
37.00
|
Announcement Date
|
4/8/20
|
4/12/21
|
4/12/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
700.9
|
793.8
|
942.9
|
1,025
|
1,135
|
1,166
|
1,220
|
1,287
|
EBITDA
1 |
177.6
|
200.7
|
351.1
|
359.8
|
310.2
|
298.6
|
326
|
343.7
|
EBIT
1 |
119.5
|
136.9
|
298.5
|
243.7
|
182.9
|
190
|
232
|
244.3
|
Operating Margin
|
17.05%
|
17.24%
|
31.65%
|
23.78%
|
16.11%
|
16.3%
|
19.02%
|
18.99%
|
Earnings before Tax (EBT)
1 |
110.1
|
125.3
|
293
|
216.3
|
106
|
138
|
188.3
|
198.5
|
Net income
1 |
77.2
|
85.83
|
209.6
|
134.2
|
62.37
|
94
|
129.6
|
139.3
|
Net margin
|
11.01%
|
10.81%
|
22.23%
|
13.1%
|
5.49%
|
8.06%
|
10.62%
|
10.83%
|
EPS
2 |
1.430
|
1.590
|
3.890
|
2.490
|
1.160
|
1.750
|
2.408
|
2.587
|
Free Cash Flow
1 |
-281.5
|
90.3
|
189.2
|
249.5
|
177.9
|
181
|
166.9
|
179.6
|
FCF margin
|
-40.17%
|
11.38%
|
20.06%
|
24.35%
|
15.67%
|
15.53%
|
13.68%
|
13.96%
|
FCF Conversion (EBITDA)
|
-
|
44.99%
|
53.88%
|
69.35%
|
57.34%
|
60.61%
|
51.2%
|
52.25%
|
FCF Conversion (Net income)
|
-
|
105.22%
|
90.26%
|
185.88%
|
285.21%
|
192.55%
|
128.76%
|
128.88%
|
Dividend per Share
2 |
0.8000
|
0.8800
|
2.170
|
1.050
|
0.8800
|
0.9000
|
1.202
|
1.350
|
Announcement Date
|
4/8/20
|
4/12/21
|
4/12/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
231.6
|
-
|
263.1
|
290.5
|
319.1
|
263
|
582.1
|
-
|
268.8
|
298.7
|
EBITDA
1 |
75.1
|
73.6
|
83.2
|
120.4
|
105.8
|
62.2
|
168
|
-
|
66.4
|
88.7
|
EBIT
|
58.09
|
32.94
|
75.84
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
25.08%
|
-
|
28.82%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
37.14
|
14.52
|
52.46
|
-
|
49.1
|
-
|
-
|
24.84
|
-
|
-
|
Net margin
|
16.03%
|
-
|
19.94%
|
-
|
15.39%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.6900
|
0.2700
|
-
|
-
|
-
|
-
|
-
|
0.4600
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/18/22
|
9/7/22
|
11/16/22
|
3/28/23
|
5/15/23
|
8/29/23
|
8/29/23
|
11/16/23
|
3/28/24
|
5/15/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
465
|
487
|
398
|
368
|
937
|
788
|
699
|
619
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.621
x
|
2.426
x
|
1.134
x
|
1.022
x
|
3.019
x
|
2.639
x
|
2.143
x
|
1.801
x
|
Free Cash Flow
1 |
-282
|
90.3
|
189
|
250
|
178
|
181
|
167
|
180
|
ROE (net income / shareholders' equity)
|
29.1%
|
26.5%
|
35.5%
|
26.1%
|
11.6%
|
16.1%
|
19%
|
18.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
14.9%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
1,407
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.180
|
5.980
|
9.240
|
9.870
|
10.00
|
10.90
|
12.80
|
13.80
|
Cash Flow per Share
2 |
1.870
|
2.440
|
4.650
|
5.360
|
4.080
|
3.360
|
3.090
|
3.060
|
Capex
1 |
46.4
|
40.8
|
61.2
|
39
|
41.5
|
41
|
47
|
48.2
|
Capex / Sales
|
6.63%
|
5.14%
|
6.49%
|
3.81%
|
3.66%
|
3.52%
|
3.86%
|
3.75%
|
Announcement Date
|
4/8/20
|
4/12/21
|
4/12/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Average target price
56.9
EUR Spread / Average Target +53.78% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.72% | 2.16B | | +38.51% | 727B | | +32.14% | 594B | | -6.23% | 354B | | +18.78% | 328B | | +1.35% | 277B | | +14.89% | 243B | | +7.79% | 205B | | -5.93% | 203B | | +6.19% | 164B |
Other Pharmaceuticals
|